News for Translate Bio, Inc. (TBIO)

With over 80 key companies active in the RNA therapies space, the market is projected to grow due to advancements in mRNA, siRNA, and antisense...

Vicore Expands and Strengthens its Board of Directors

Notice of Annual General Meeting of Vicore Pharma Holding AB (publ)

Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the...

TBIO | Complete Telesis Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Newark, New Castle, USA, June 30, 2023 (GLOBE NEWSWIRE) -- In accordance with the recent Growth Plus Reports study, the Global mRNA Therapeutics Market...

Mr. Burgess will be responsible for leading Cerevel’s business development and quality teams Mr. Burgess to join Cerevel effective June 20, 2023 ...

The RNA interference therapy pipeline and clinical trial analysis report deliver important insights on ongoing research, clinical strategies, upcoming...

Ron Renaud to succeed Tony Coles, M.D. as CEO, effective June 12, 2023; Dr. Coles will continue as chairperson of the board Mr. Renaud brings more than 25...

/PRNewswire/ -- The "mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been...

Newark, New Castle, USA, Feb. 07, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global RNAi Therapeutics Market was...

/PRNewswire/ -- The "Global mRNA Therapeutics Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Oncology), by Type (Prophylactic...

CAMBRIDGE, Mass., Sept. 20, 2022 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of Phillip... | September 20, 2022

The Cystic Fibrosis (CF) therapeutic development pipeline contains candidate drugs that address many different aspects of the disease. Drug development for...

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors CAMBRIDGE, Mass., / PRNewswire/ -- Blueprint Medicines Corporation today announced the appointment of... | December 10, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that th...

The French drug maker intends to fill vials and finish packaging of as many as 200 million doses

In this article, we discussed billionaire Seth Klarman's top 10 stock picks for 2021. You can skip our detailed analysis of Klarman's latest moves and...

One of the best resources for investors are the publicly available 13F-HR documents that each fund is required to submit to the SEC. These documents allow inves...